Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;50(1):93-100.
doi: 10.1080/02713683.2024.2397028. Epub 2024 Sep 18.

Development of Microcystoid Macular Degeneration in the Retina of Nonhuman Primates: Time-Course and Associated Pathologies

Affiliations

Development of Microcystoid Macular Degeneration in the Retina of Nonhuman Primates: Time-Course and Associated Pathologies

Thomas C M Lavery et al. Curr Eye Res. 2025 Jan.

Abstract

Purpose: Microcystoid macular degeneration (MMD) is a condition where cystoid vacuoles develop within the inner nuclear layer of the retina in humans in a variety of disorders. Here we report the occurrence of MMD in non-human primates (NHPs) with various retinal ganglion cell (RGC) pathologies and evaluate the hypothesis that MMD does not precede RGC loss but follows it.

Methods: Morphological studies were performed of the retinas of NHPs, specifically both rhesus (Macaca mulatta) and cynomolgus macaques (Macaca fascicularis), in which MMD was identified after induction of experimental glaucoma (EG), hemiretinal endodiathermy axotomy (HEA), and spontaneous idiopathic bilateral optic atrophy. In vivo imaging analyses included fundus photography, fluorescein angiography (FA), optical coherence tomography (OCT), adaptive optics scanning laser ophthalmoscopy (AOSLO), light microscopy, and electron microscopy.

Results: MMD, like that seen on OCT scans of humans, was found in both rhesus and cynomolgus macaques with EG. Of 13 cynomolgus macaques with chronic EG imaged once with OCT six of 13 animals were noted to have MMD. MMD was also evident in a cynomolgus macaque with bilateral optic atrophy. Following HEA, MMD did not develop until at least 2 weeks following the RNFL loss.

Conclusion: These data suggest that MMD may be caused by a retrograde trans-synaptic process related to RGC loss. MMD is not associated with inflammation, nor would it be an independent indicator of drug toxicity per se in pre-clinical regulatory studies. Because of its inconsistent appearance and late development, MMD has limited use as a clinical biomarker.

Keywords: Microcystic macular degeneration; endodiathermy axotomy; experimental glaucoma; inner nuclear layer; optic atrophy.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

The authors have no relationships that could be viewed as presenting a potential conflict of interest.

Similar articles

Cited by

References

    1. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ. Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol May 2013;70(5):629–33. doi:10.1001/jamaneurol.2013.1832 - DOI - PubMed
    1. Petzold A Microcystic macular oedema in ms: T2 lesion or black hole? Lancet Neurol Nov 2012;11(11):933–4. doi:10.1016/S1474-4422(12)70231-4 - DOI - PubMed
    1. Ortiz-Perez S, Martinez-Lapiscina EH, Gabilondo I, Fraga-Pumar E, Martinez-Heras E, Saiz A, Sanchez-Dalmau B, Villoslada P. Retinal periphlebitis is associated with multiple sclerosis severity. Neurology. Sep 3 2013;81(10):877–81. doi:10.1212/WNL.0b013e3182a3525e - DOI - PMC - PubMed
    1. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: A retrospective study. Lancet Neurol Nov 2012;11(11):963–72. doi:10.1016/S1474-4422(12)70213-2 - DOI - PMC - PubMed
    1. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. Jun 2012;135(Pt 6):1786–93. doi:10.1093/brain/aws098 - DOI - PMC - PubMed

LinkOut - more resources